MicroRNA News and Research

RSS
In genetics, microRNAs (miRNA) are single-stranded RNA molecules of 21-23 nucleotides in length, which regulate gene expression. miRNAs are encoded by genes from whose DNA they are transcribed but miRNAs are not translated into protein (i.e. they are non-coding RNAs); instead each primary transcript (a pri-miRNA) is processed into a short stem-loop structure called a pre-miRNA and finally into a functional miRNA. Mature miRNA molecules are partially complementary to one or more messenger RNA (mRNA) molecules, and their main function is to down-regulate gene expression.
Asuragen, Novartis to develop ARQ BCR-ABL1 RNA IS Calibrators, laboratory software reporting tools

Asuragen, Novartis to develop ARQ BCR-ABL1 RNA IS Calibrators, laboratory software reporting tools

EPO upholds Alnylam's Tuschl II 1407044 patent

EPO upholds Alnylam's Tuschl II 1407044 patent

MicroRNA linked to mosquito blood digestion and egg development identified

MicroRNA linked to mosquito blood digestion and egg development identified

Mount Sinai’s instructor receives Liz Tilberis Grant from OCRF

Mount Sinai’s instructor receives Liz Tilberis Grant from OCRF

miRagen and t2cure enter licensing agreement for microRNA 92 technology

miRagen and t2cure enter licensing agreement for microRNA 92 technology

Overexpression of microRNA 125b can cause leukemia: Research

Overexpression of microRNA 125b can cause leukemia: Research

Blocking miR-375 microRNA in ERalha-positive breast cancer cells slows down cancer cell growth

Blocking miR-375 microRNA in ERalha-positive breast cancer cells slows down cancer cell growth

Largest genomic study of human medulloblastomas

Largest genomic study of human medulloblastomas

Agilent's GeneSpring Bioinformatics Solution integrated with GeneGo's MetaCore

Agilent's GeneSpring Bioinformatics Solution integrated with GeneGo's MetaCore

K.U.Leuven researchers receive ERC Advanced Grants

K.U.Leuven researchers receive ERC Advanced Grants

Alnylam presents data on RNAi technologies at MIT Center Summit

Alnylam presents data on RNAi technologies at MIT Center Summit

Alnylam comments on Roche's corporate restructuring for RNAi therapeutics

Alnylam comments on Roche's corporate restructuring for RNAi therapeutics

Amsterdam 2010 third quarter total expense increases from EUR 4.4 million to EUR 4.7 million

Amsterdam 2010 third quarter total expense increases from EUR 4.4 million to EUR 4.7 million

Sistemic launches early predictive and investigative drug toxicity screening service

Sistemic launches early predictive and investigative drug toxicity screening service

Mirna to present data on miRNA Replacement Therapies for cancer at CPRIT Conference

Mirna to present data on miRNA Replacement Therapies for cancer at CPRIT Conference

Isis, Xenon enter collaboration to discover and develop antisense drugs for AI

Isis, Xenon enter collaboration to discover and develop antisense drugs for AI

Dutch government awards Innovation Credit of EUR 1.3 million to InteRNA

Dutch government awards Innovation Credit of EUR 1.3 million to InteRNA

New stem cell-infused patch improves heart function after myocardial infarction

New stem cell-infused patch improves heart function after myocardial infarction

RNA-based drugs may prevent premature birth: Research

RNA-based drugs may prevent premature birth: Research

Exiqon publishes clinical study data on colon cancer

Exiqon publishes clinical study data on colon cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.